Cytox (AgeTech UK) NeuroTech
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.
Connections from
Headquarters:
United Kingdom
Funding Status:
N/A
Employee Number:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
AgeTech Companies
Investor Type:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020